PMID: 102330Nov 1, 1978Paper

Coronary and myocardial metabolic effects of combined glyceryl trinitrate and propranolol administration. Observations in patients with and without coronary disease

British Heart Journal
S J Schang, C J Pepine


Coronary haemodynamic and metabolic effects of propranolol and glyceryl trinitrate were studied in 12 patients with coronary artery disease and 5 without coronary heart disease, at rest and during tachycardia stress. Propranolol-associated reductions in indices of myocardial oxygen demand, left ventricle work, tension time, and left ventricle oxygen utilisation (LVVO2) were reversed when heart rate was controlled by atrial pacing. Adding glyceryl trinitrate at rest also restored heart rate but decreased the left ventricular work index and tension time index as coronary resistance declined paradoxically. Tachycardia-related increases in tension time index and LVVO2 were unchanged after propranolol, and ischaemia (angina, ST depression, and reduced lactate extraction) was not altered in most of the patients. During tachycardia, the addition of glyceryl trinitrate decreased the tension time index and LVVO2; angina recurred in only 4 patients, and ST depression and lactate extraction improved. Similar haemodynamic changes occurred in the patients with normal coronary arteries. In contrast with propranolol administered alone, propranolol plus glyceryl trinitrate enhances tachycardia tolerance and prevents tachycardia-induced manifes...Continue Reading


Jan 1, 1975·Catheterization and Cardiovascular Diagnosis·F J Klocke
Jan 1, 1972·Progress in Cardiovascular Diseases·R E Goldstein, S E Epstein
Nov 1, 1973·Circulation·R J BarnardG D Buckberg
Aug 1, 1967·Circulation·E RobinR J Bing
Jan 1, 1972·Circulation Research·G D BuckbergJ I Hoffman
Jan 1, 1968·The American Journal of Cardiology·H I Russek
Jan 1, 1968·Cardiovascular Research·P D SteinJ W Hyland
Sep 1, 1966·The American Journal of Cardiology·S WolfsonR Gorlin
Jun 1, 1965·British Journal of Pharmacology and Chemotherapy·J R PARRATT

❮ Previous
Next ❯


Jan 1, 1992·Microbiology and Immunology·T NakagamiK Yamanishi
Dec 1, 1986·The American Journal of Cardiology·A L SowardP W Serruys
Apr 1, 1981·Seminars in Nuclear Medicine·R M SteingartM D Blaufox
Jan 1, 1988·Catheterization and Cardiovascular Diagnosis·J T MillerR L Henry
Feb 1, 1988·The American Journal of Cardiology·H SuryapranataP G Hugenholtz
Jun 20, 1989·The American Journal of Cardiology·H Suryapranata, P W Serruys
Jun 25, 1987·The New England Journal of Medicine·J O Parker
Jan 1, 1990·Free Radical Research Communications·R Stocker
Nov 1, 1986·Postgraduate Medicine·P C Deedwania, E V Carbajal

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.